주식/증권
📈 긍정적
ETFs to Buy Post JNJ's Q2 Earnings Beat & Bullish 2026 Outlook
요약
Johnson & Johnson's Q2 beat and strong pharma momentum are raising interest in healthcare ETFs with sizable exposure to the company.